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Short-term sensory and cutaneous vascular
responses to therapeutic ultrasound in the
forearms of healthy volunteers
Shaguftha Sultana Shaik1*, Joy C MacDermid1,2,3, Trevor Birmingham4, Ruby Grewal5 and Baseer Farooq6
Abstract
Background: Therapeutic ultrasound (US) is used for a variety of clinical pathologies and is thought to accelerate
tissue repair and help with pain reduction via its thermal and nonthermal effects. The evidence on physiological
effects of US on both sensory and vascular functions in humans is incomplete. Hence, the purpose of this study was
to determine the short-term impact of two doses of US (3 MHz, 1:4, 0.25 W/cm2, 5 min; 1 MHz, continuous, 0.8 W/cm2,
3 min), on sensory and vascular responses in the healthy forearms.
Methods: Twenty healthy subjects were recruited (mean age, 29.6 ± 8.8 years) for the study. Superficial blood flow
(SBF) in the distal forearms was determined using the tissue viability imaging system. Sensory perception thresholds
(SPT) were determined from ring finger (C7, C8) to assess A-beta (at 2,000 Hz) and C fiber function (at 5 Hz), using a
Neurometer CPT/C device. Subject’s two hands were randomly allocated to group order (AB/BA). Scores were obtained
before and immediately after the application of US and control. Differences in these were analyzed using repeated
measures.
Results: Both 3 MHz pulsed US and 1 MHz continuous US showed small to moderate (effect size = 0.12 to 0.68),
statistically significant reductions in SBF (3 MHz, mean change = 2.8 AU and 1 MHz, mean change = 3.9 AU, p < 0.05
respectively), skin temperature (2.5°C and 1.1°C, p < 0.05), and SPT at 5 Hz (1.3 and 1 mA, p < 0.05) across time. SPT at
2,000 Hz remained unaltered by all three conditions (p > 0.05). Age and gender also had no effect on all outcome
measures (p > 0.05).
Conclusion: This study demonstrated minor reductions in skin blood flow, skin temperatures, and C fiber perception
thresholds immediately after 3 MHz, and 1 MHz US. The responses observed may have been due to a thermo-cooling
effect of the gel or due to the direct effect of US on C fibers of median and ulnar nerves. US had a negligible effect
on A-beta fibres. This would suggest that future studies looking at physiological effects of US should move towards
investigating larger dosages and study the effects in patient populations.
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Background
Therapeutic ultrasound (US) is a physical agent modality
that has been used in hand clinics for the management
of various musculoskeletal injuries for over 50 years [1-6].
Physiological and therapeutic properties of US are attrib-
uted to various nonthermal and thermal responses [4,6-9].
The tissue response to nonthermal ultrasound includes
acceleration of tissue healing through cavitation and its as-
sociated effects [3,6,8,10,11], while the responses to ther-
mal ultrasound include increases in tissue temperature at
superficial and deep levels such as tendons, ligaments,
joint capsules, and fascia without overheating underlying
fat [3,7,10-13]. Both continuous and pulsed ultrasound are
thought to show nonthermal effects and accelerate tissue
repair [1-3,6,11,14,15], while continuous ultrasound is
thought to add additional therapeutic effects due to heat-
ing [6,11,13,16]. Although US has been used for decades,
the lack of definitive studies defining its benefit in
* Correspondence: shagufthapt@yahoo.co.in
1Faculty of Health Sciences, Department of Health and Rehabilitation
Sciences, Physical Therapy Field, Western University, London, ON N6G 1H1,
Canada
Full list of author information is available at the end of the article
© 2014 Shaik et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Shaik et al. Journal of Therapeutic Ultrasound 2014, 2:10
http://www.jtultrasound.com/content/2/1/10
different musculoskeletal conditions [4,8-10,17,18] has
questioned the traditional view of its therapeutic benefits
[10]. Multiple systematic reviews and meta-analyses of US
has failed to provide definitive conclusions about the ef-
fectiveness (or lack of effectiveness) of US because of in-
sufficient evidence [4,6,8-10,17,18]. Several reviews also
report disagreement and confusion about the most effica-
cious treatment parameters for US [4,6,8-10,17,18,20].
Despite this lack of strong evidence, previous reports on
US usage in the form of questionnaires and surveys have
shown that US is being used frequently in the physio-
therapy clinical practice for musculoskeletal conditions
[9,21-23,25]. It was found that over 70% to 95% experi-
enced and advanced practice clinicians continue to use
US regularly for specific impairments encountered in
orthopedic and sports settings, indicating that US is
perceived as an important component in the manage-
ment of selected impairments [9,21-23,24,25]. Although
dosage is based on the theoretical rationale, there are in-
sufficient dosage trials to define the optimal dosage of
ultrasound across different conditions [4,6,9,19,21].
Ultrasound is thought to affect tissue thermodynamics
and as such might result in changes in the peripheral
circulatory system. A therapeutic modality capable of al-
tering peripheral circulation could affect the health of hu-
man tissue and facilitate tissue healing [8,20]. The forearm
skin (nonglabrous) is innervated by sensory nerves and
sympathetic vasoconstrictor and vasodilator nerves, which
respond to thermal, chemical, and mechanical stimuli to
provide feedback to the central nervous system and in-
fluence cutaneous arteriolar tone (vasoconstriction or
vasodilation) via the release of neuropeptides and other
vasoactive agents [26-28]. After injury, symptoms of pain
can occur because of vascular insufficiency which affects
metabolic function in the injured soft tissue or edema and
muscular strain, etc. [29]. Alterations in pain can also be
related to neural transmission in sensory and pain fibers
[29]. Better understanding of the biological effects of
ultrasound should include monitoring all these path-
ways (vascular and neural).
There is currently a scarcity of published clinical trials
that have looked at both the neural and vascular re-
sponses to ultrasound therapy. Noble et al. used laser
Doppler flowmetry (LDF) to assess cutaneous blood flow
and concomitant measures of ambient and skin temper-
atures after applying 3 MHz pulsed (1:2) and 3 MHz
continuous US at an intensity of 1 W/cm2 for 6 min
over the mid-forearm [30]. The authors noted that after
sonation, there was an increase in skin blood perfusion
with pulsed US and continuous application of US with-
out any significant difference in skin temperature be-
tween the US groups. However, these authors measured
skin blood flow distal to the US application from a single
vessel (single point LDF) instead of the tissues directly
affected by the treatment. Further, they did not include
sensory monitoring to establish changes in nerve func-
tion with ultrasound application [30].
The effects of US are thought to vary with the type of
tissue, site, and the dosage used [6,8,11,12,19-21,31].
There is a scarcity of information regarding the effects
of ultrasound on hemodynamics resulting from altered
treatment times, intensities, and frequencies in human
subjects. These evaluations might inform our under-
standing for potential mechanisms of therapeutic effect
that operate through beneficial effect on skin blood flow
and sensory function. Hence, the purpose of this study
was to determine the effects of two different doses of US
(3 MHz pulsed and 1 MHz continuous) on superficial
blood flow, skin temperature, and sensory perception
thresholds in the distal forearms of healthy volunteers.
A secondary purpose was to determine if the responses
were affected by age and gender.
Methods
Participants
The sample size required for this research was based on
the number needed to detect a moderate effect size ac-
cording to Cohen [32]. A moderate effect (ES r = 0.50)
using two-tailed alpha (α = 0.05) at 80% power requires a
sample of 28 participants in each group for a between-
subject design and a sample of 14 participants for a
within-subject design. As this is a within-subject design
and variance within individuals is less than between sub-
jects, a sample size of 20 was considered and approved
by the Ethics Board. Statistical significance was consid-
ered if p < 0.05.
Subjects were recruited by poster advertisement and
word of mouth in the university campus. Testing was
done in Hand and Upper Limb Research Lab, at St
Joseph’s Health Care, London, Ontario, Canada. Healthy
subjects aged 18 to 50 years with no recent injury or
disease at neck, shoulder, elbow, wrist, or hand within
the past year were included in the study. Subjects were
divided into two age categories: 18–34 and 35–50 years.
There were ten males and ten females in total. Please
refer to Table 1 for subject demographics. All subjects
were informed to refrain from exercise and drinking
Table 1 Demographic characteristics of participants
Age, years (M ± SD) 29.6 ± 8.83
Gender
Females, n (%) 10 (50%)
Males, n (%) 10 (50%)
Dominance
Right, n (%) 19 (95%)
Left, n (%) 3 (5%)
M mean, SD standard deviation, n number of participants.
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beverages 4 h prior to testing. Subjects were excluded if
they had ecchymosis, skin infection, open wound, swell-
ing, neurovascular injuries, deficits in sensation in the
area to be treated (sensory test to identify sharp and dull
sensation; hot or cold), decreased circulation (digital pa-
tency test for fingers), pregnancy, presence of a pace-
maker/monitoring device, malignancy, hypertension, and
cardiac failure. This study was approved by the Western
University Research Ethics Board. All participants read the
letter of information, had his/her questions answered, and
signed a consent form prior to participation in this study.
Equipment
Ultrasound machine
A ‘Phyaction U’ ultrasound machine (GymnaUniplay N
V, Pasweg 6A, and BILZEN) with the capabilities for 1
and 3 MHz frequency operation was used to deliver the
ultrasound treatments. The transducer, model U92, had
an effective radiating area of 4.0 cm2 and a beam non-
conformity ratio (BNR) of <4.0 and was calibrated before
research was initiated. An aqueous Eco Gel (Eco-med
Pharmaceuticals, Mississauga, ON, Canada) was used as
the coupling medium for all treatments.
We could not find any clear standard guidelines for
US dosage in the literature [21,31]; hence, we adopted
the framework proposed by Tim Watson [20,33]. Based
on the previous evidence on the effectiveness of ultra-
sound, he put forth a framework for the treatment par-
ameter selection [33]. The basic principle is that the
more acute and irritable the tissue in question, the lower
the required dose to achieve a stimulating effect. The
frequency selection (1 or 3 MHz) will influence the ef-
fective treatment depth (3 MHz is more superficial, i.e.,
a depth of approximately 2 cm, 1 MHz is effective to a
depth of 4 or 5 cm). The pulse ratio needs to be higher
for the more acute lesions (1:4) and lower for the more
chronic (1:1 or continuous). Intensities vary from 0.1 to
0.3 W/cm2 for the acute lesions to 0.4 to 0.7 or 0.8 W/cm2
for the chronic lesions. Treatment times are based on
the principle of 1 min of ultrasound per treatment head
area [20,33]. Hence, we derived two experimental dos-
ages from the above framework which may be applicable
for tissue healing in an acute condition (3 MHz, pulsed
US, for a lesion <1 cm depth) and a chronic condition
(1 MHz, continuous, for a lesion <3 cm depth) at the
distal forearm. Subjective skin warmth was used as an
indicator of tissue heating and dose selection [6,34].
TiVi 600 polarization spectroscopy camera
The tissue viability imager (TiVi, version 7.4 Wheels
Bridge AB, Linköping, Sweden) is a small and portable
device for high-resolution instantaneous imaging of
red blood cell (RBC) concentration in upper human
dermal tissue. TiVi software was used to quantify RBC
concentration on the anterior aspect of the distal fore-
arm on both arms using a digital camera (Canon Rebel
EOS model 450D, Tokyo, Japan) with a polarization lens.
The camera was adjusted to point downwards and paral-
lel to the surface of the desk. A royal blue-colored cush-
ion was used to rest the forearm and to fill the camera
view. An outline was drawn to standardize hand posi-
tioning. The participants were positioned with their
shoulder in neutral, elbow in 90° flexion, wrist in neutral
position, and the forearm fully supinated and placed ap-
proximately at the level of the heart. Each image was
captured with the polarized lens set at the ‘cross
polarization’ setting and the camera was positioned at a
distance between 30 cm from the participant’s hand.
Image quality was set to ‘medium normal’. The camera
has a light penetration depth between 0.4 to 0.5 mm
[35], and this light contains information about the main
chromophores in the epidermis (melanin) and dermis
(hemoglobin), while the surface reflections contain infor-
mation about the surface topography, such as texture
and wrinkles. Once the images were captured, they
were processed using the TiVi software.
For each participant, one image at baseline and immedi-
ately after US therapy and control (rest) were used for
processing and analysis. There were a total of eight images
per participant (four in each arm). Regions of interest
(ROI) were selected over the treatment area (2× effective
radiating area or ERA) at the distal forearms. The magni-
tude of RBC concentration over the selected ROI’s was
obtained using ‘image analysis’. Values for the TiVi are
measured by arbitrary units (AU) as defined by the manu-
facturer. Data was first exported from the TiVi software
into Microsoft Excel and then imported into SPSS version
20.0 for statistical analysis. The technique has shown
many uses in drug development, burn investigations, pres-
sure studies, and general research maneuvers due to the
ease of use, portability, and low cost [35,36]. The TiVi has
been validated for construct validity to measure superficial
RBC concentrations with in vitro fluid models and com-
puter simulations. TiVi software is able to accurately cal-
culate the oxygen saturation level of 91.5% in vivo, which
is within the physiological range of oxygen saturation
within blood [35,37]. It has been shown to be sensitive to
change during blood occlusion testing [35], and drug test-
ing on skin [38], and has also demonstrated good inter-
laboratory reliability [39].
Neurometer® CPT/C device
The Neurometer® CPT/C device (Neurotron Inc., Baltimore,
MA, USA) evaluates sensory nerve conduction from the
periphery to the brain and has been shown to detect dif-
ferences in neural function in asymptomatic subjects
when neural stress was administered [40]. This portable
battery-operated nerve stimulator has the ability to emit
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three different frequencies in sinusoidal waveforms to se-
lectively target different subpopulations of nerve fibers
dependent upon nerve fiber diameter. A frequency of
2,000 Hz is used to stimulate the large myelinated A-beta
fibers (Aβ fibers) which detect cutaneous touch and pres-
sure; a 250-Hz stimulus will stimulate myelinated A-delta
nerve fibers (Aδ fibers) which are mechanoreceptive and
detect fast pain, pressure, and temperature, while a fre-
quency of 5 Hz is used to stimulate the small unmyelin-
ated C-polymodal nociceptive fibers which detect slow
pain and temperature and are postganglionic sympathetic
fibers. This device has been used in numerous studies to
detect, screen, and diagnose the abnormalities of periph-
eral nervous system and normal ranges for all nerve fiber
types (A-beta, A-delta and C fibres) that have been estab-
lished to assess normal sensation, increase in sensation
(hyperesthesia), decrease in sensation (hypoesthesia), and
no sensation at all (anesthesia) [41,42]. The neurometer
has been shown to be both specific (73%) and sensitive
(74%) in the clinical examination of carpal tunnel syn-
drome and is considered a reliable and valid measure of
quantitative sensory function [43].
Ranged CPT (R-CPT) is a sensory perception thresh-
old test which can be completed in 3 to 6 min for each
test site. It is typically used to confirm or rule out sen-
sory involvement in large samples such as in screening
and monitoring therapeutic outcomes [41,42]. In R-CPT,
each frequency is repeated several times to ensure accur-
acy and reproducibility. The average time needed to
complete the tests is reported to be less than 10 min
[41,42]. The neurometer reports values as the normal
range (R-CPT level, 6–13), hyperesthesia (R-CPT level,
1–5), and hypoesthesia (R-CPT level, 14–25) [41,42].
Sensory nerve perception thresholds at two frequencies,
2,000 and 5 Hz, to test two different nerve fibers that
were used in this study. To begin 2,000-Hz stimulation,
the skin was cleaned with a skin paste and then the
1 cm gold electrodes coated with small amount of gel
were attached to the ring finger (area innervated by C7,
C8) with an adhesive tape. Then, the participants were
asked to press and hold the red ‘Test cycle’ button on
the remote control box and release it as soon as they
begin to feel the tingling or buzzing sensation. The ma-
chine records the response when the button is released
and the same process is repeated 7–10 times until a
score is displayed. In total, three scores are obtained at
2,000 Hz. The same procedure is repeated at 5 Hz.
These test cycles end automatically after few repetitions
(7–10 times), and the machine displays score for 5 Hz.
Experimental procedure
Randomization
We used a randomized cross over, repeated measures
design in this study. Random allocation to treatment
order and hand was achieved through subject’s selection
of assignment contained in an opaque envelope. After
explaining the protocol and obtaining consent, each par-
ticipant was asked to pick up two different colored
sealed envelopes from two bundles, which had informa-
tion on the side of hand and sequence of therapy to be
initiated. Once the hand side was picked, the participant
was then randomized to either pulsed US group or con-
tinuous US group based on the labeling on cards inside
these envelopes. There were three conditions for testing:
a control condition (or rest), pulsed ultrasound, and
continuous ultrasound. If the card showed pulsed US
group, then the order of therapy was pulsed US followed
by rest in the hand first selected. After this, the opposite
hand received therapy in reverse order (continuous US
group), beginning with rest and then followed by the
continuous US. A 25-min gap [13] was established be-
tween each treatment condition (control/rest, pulsed,
and continuous US) to provide a washout period and to
minimize any potential carry over effects of US. Each
hand acted as its own control. Therapy instructions and
outcome assessments were all provided by a single physio-
therapist. The two group sequences were completed on
the two hands one after the other on the same day. The
flow chart outlining the study design is in Figure 1.
Ultrasound protocol
After acclimatization to room temperature for 10 min,
participants were first measured using the TiVi over the
treatment area in distal forearms. This was followed by
skin temperature measurement using King’s infrared
digital thermometer. Then, a range-CPT test was re-
corded from the tips of ring finger (over C7/C8 derma-
tome level) to assess sensory perception thresholds at
2,000 Hz (for A-beta fibres) and 5 Hz (for C fibres).
These three measurements (TiVi, temperature, R-CPT)
were done before (pretest or baseline) and immediately
(post-test) after each control condition/rest and ultra-
sound application in similar order. After completing
baseline assessments, based on the group order selec-
tion, participants either underwent therapy with con-
tinuous US or pulsed US or were informed to rest for 3
to 5 min without any treatment, during the control/rest
conditions. The next therapy was initiated after 25 min
during which the skin temperature returned to its pre-
treatment level. To ensure that the ultrasound was di-
rected at the target tissue, a template equivalent to twice
the area of ultrasound applicator (2× ERA) was placed
on the anterior aspect of distal forearm (distal border
coinciding with the ulnar styloid process). Pulsed US
was delivered at 3 MHz pulsed mode, with 1:4 duty
cycle, at an intensity of 0.25 W/cm2 for 5 min. Whereas,
continuous US was delivered at 1 MHz, continuous
mode, with an intensity of 0.8 W/cm2 for 3 min (adapted
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from T. Watson) [15,33]. The ultrasound applicator was
moved back and forth (circular motion) in the template
at a rate of 3 to 4 cm/s continuously and was timed with
a metronome. Instructions were given to the participants
to inform if the therapy was uncomfortable, in order to
stop the machine and note the time of discomfort-free
therapy. After US therapy, the treatment area was
cleaned with a towel and then TiVi, skin temperature,
and R-CPT responses were measured immediately
after (post-test). The same process was repeated after
control/rest.
TiVi software was used to calculate the mean blood
flow (AU) in the treatment area and then the data was
transferred to an Excel sheet (Microsoft 2010). The sen-
sory perception thresholds obtained at 2,000 and 5 Hz
(mA) were recorded directly from the digital display of
the Neurometer CPT/C device along with temperature
(°C) readings onto a separate data collection sheet. Sub-
jects were instructed to keep the area clean and covered
and to self-monitor for any signs of local skin irritation
after they leave.
Data analysis
Data was entered in SPSS and random checks of 10%
of the data against the hard copies of data sheets was
Figure 1 Flow chart for the study design (cross-over AB/BA).
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used to ensure data quality (100% were correct so no
further data audits were performed). Descriptive statis-
tics were run to further investigate data quality and as-
sess data normality. The majority of data was normally
distributed as assessed by Kolmogorov-Smirnov test
(p > 0.05); hence, parametric tests were used for quan-
titative data analysis. The outcome measures (RBC
concentration, temperature, and sensory perception
thresholds) were assessed for differences using general
linear models, repeated measures (GLM, RM using
SPSS version 20, IBM Inc., Chicago, IL, USA). Models
assessed whether there were differences between base-
line and immediately after control or ultrasound ther-
apy (1 and 3 MHz). Interactions were examined for
significance between time and treatment group. Post
hoc analyses were performed using Bonferroni correc-
tion wherever necessary. Pairwise comparisons were
used to perform within-group comparisons for treat-
ment and control. The GLM model was run without
covariates and then repeated with age and gender as a
covariate to test for differential responses. Significance
level was set at p < 0.05 level unless otherwise noted. All
values were expressed as means, standard deviation, and
confidence intervals.
Results
Twenty healthy volunteers were recruited between November
2012 and February 2013. No data points were missing.
Demographic information of participants is presented in
Table 1. The group means, standard deviation (SD), 95%
confidence interval (CI), effect size (ES), and change
scores (CS) for skin blood flow, skin temperature, and
sensory perception thresholds at 2,000 and 5 Hz are
shown in Tables 2 and 3 and are summarized by outcome
measure in the following.
Sensory perception threshold at 2,000 Hz from ring finger
No significant difference in sensory perception threshold
at 2,000 Hz was observed in the ultrasound or control,
across the time points. There was no significant inter-
action between time and treatment (Table 3 and Figure 2).
Sensory perception threshold at 5 Hz from ring finger
A significant decrease in perception threshold at 5 Hz
was observed from pretest to post-test with US (either 1
or 3 MHz) as well as control condition (p < 0.05). A sig-
nificant interaction was also found between time and
treatments (p < 0.05). Post hoc comparisons revealed that
control condition resulted in a statistically significant de-
crease in threshold (13.4 to 10.6 mA) when compared to
pulsed US at 3 MHz (13.4 to 12.2 mA) (p < 0.05) in the
pulsed US group. The post hoc comparisons between
continuous US at 1 MHz (12.4 to 11.4 mA) and control
condition (12.0 to 10.8 mA) showed no significant differ-
ence (p > 0.05). However, the change in perception
threshold was greater after control (2.8 mA in pulsed US
group and 1.6 mA in continuous US group; p < 0.05)
than after the pulsed US (1.1 mA) or continuous US
therapy (1.0 mA) (p < 0.05) (Table 3 and Figure 3).
Skin blood flow over treatment area
There was a significant decrease in skin blood flow over
the treatment area from baseline to post-test after the
ultrasound (1 or 3 MHz) and control condition (p <
0.05). A significant interaction was also found between
time and treatments (p < 0.05). Post hoc comparisons re-
vealed that pulsed US at 3 MHz resulted in a statistically
significant decrease in superficial blood flow (60.3 to
57.6 AU) as compared to that of the control condition
(60.3 to 60.1 AU) (p < 0.05) in the pulsed US group.
Similarly, the post hoc comparisons between continuous
US at 1 MHz showed a significant decrease in blood
flow (60.6 to 56.9 AU) as compared to that in the con-
trol (60.6 to 59.9 AU) (p < 0.05) in the continuous US
group. The change in blood flow was very small after
control (1.1 AU in pulsed US group and 1 AU in con-
tinuous US group; p < 0.05) than after the pulsed US
(2.5 AU) or continuous US therapy (3.5 AU) (p < 0.05)
(Table 2 and Figures 3, 4, and 5).
Skin temperature over the area of treatment
A significant decrease in temperature was also observed
over the treatment area from pretest to post-test with
ultrasound (1 or 3 MHz) as well as control condition
(p < 0.05). A significant interaction was also found
between time and treatments (p < 0.05). Post hoc com-
parisons revealed that pulsed US at 3 MHz resulted in a
statistically significant decrease in skin temperature
(33.0°C to 30.9°C) when compared to the control
condition over the treatment area (33.1°C to 33.0°C)
(p < 0.05). Similarly, the post hoc comparisons between
continuous US at 1 MHz showed statistically significant
decrease in skin temperature (33.1°C to 32.1°C) when
compared to the control condition (33.4°C to 33.1°C) (p <
0.05). The change in temperature was very small with
control (0.05°C in pulsed US group and 0.3°C in con-
tinuous US group) than that after the pulsed US (2°C)
or continuous US (1.5°C) (p < 0.05). However, partici-
pants reported that they felt the skin and the transducer
head became slightly warmer during or after continuous
US (1 MHz) but did not report this during or after
pulsed US therapy (3 MHz) (Table 2 and Figure 6).
Effect of age and gender
Analysis with age and gender as covariates revealed no
significant effect of age (across the two categories; 18–34,
35–50 age groups) as well as the gender on the R-CPT
Shaik et al. Journal of Therapeutic Ultrasound 2014, 2:10 Page 6 of 15
http://www.jtultrasound.com/content/2/1/10
Table 2 Summary of results for skin blood flow and skin temperature over the treatment area
Pulsed US group Continuous US group
Pulsed US (3 MHz)a Control-p Control-c Continuous US (1 MHz)b
Before After CS ES Before After CS ES Before After CS ES Before After CS ES
Bf M 60 M 57.6 2.8* 0.12 M 60.3 M 60 1.1* −0.07 M 60.6 M 59.9 0.8* 0.03 M 60.6 M 56.9 3.5* 0.2
SD 10.6 SD 11.2 SD 10.7 SD 8.8 SD 8.9 SD 9.9 SD 8.9 SD 10.6
CI (55–65) CI (52–62) CI (55–64) CI (57–66) CI (56–64) CI (54–64) CI (56–64) CI (51–61)
St M 33.1 M 30.9 2.1* 0.68 M 33.1 M 33 0.1* −0.04 M 33.4 M 33.1 0.3* 0.2 M 33.1 M 32.1 1.0* 0.42
SD 1.1 SD 1.1 SD 1.2 SD 0.8 SD 1.0 SD 0.9 SD 1 SD 1.2
CI (33–34) CI (30–32) CI (33–34) CI (33–33) CI (33–34) CI (33–34) CI (32–34) CI (31–33)
aPulsed mode, 3 MHz, 2.5 W/cm2, 5 min.; bcontinuous mode, 1 MHz, 0.8 W/cm2, 3 min. Control-p no US therapy in pulsed US group, Control-c no US therapy in continuous US group, Tx treatment, M mean, CI 95%

















Table 3 Summary of results for sensory perception thresholds at 2,000 and 5 Hz from ring finger
Pulsed US group Continuous US group
Pulsed US (3 MHz)a Control-p Control-c Continuous US (1 MHz)b
Before Aftre CS ES Before After CS ES Before After CS ES Before After CS ES
Aβ M 8.5 M 7.6 0.9 0.14 M 8.5 M 7.1 1.3 0.12 M 8.6 M 7.8 0.8 0.2 M 8.6 M 8.0 0.7 0.1
SD 3.8 SD 1.7 SD 3.8 SD 1.8 SD 2.4 SD 1.7 SD 2.4 SD 2.2
CI (6.8–10) CI (7.5–9.7) CI (6–10) CI (7–8) CI (6–8) CI (7–9) CI (7–9) CI (6.9–9)
C M 13.4 M 12.2 1.3* 0.17 M 13.4 M 10.5 2.8* 0.36 M 12 M 10.8 1.6* 0.2 M 12.4 M 11.4 1* 0.1
SD 3 SD 3.6 SD 3 SD 3.8 SD 4.3 SD 3.9 SD 4.4 SD 3.6
CI (12–15) CI (10–13) CI (12–14) CI (8–12) CI (10–15) CI (9–13) CI (10–14) CI (9.8–13)
aPulsed mode, 3 MHz, 2.5 W/cm2, 5 min.; bcontinuous mode, 1 MHz, 0.8 W/cm2, 3 min. Control-p no US therapy in pulsed US group; Control-c no US therapy in continuous US group, Tx treatment, M mean, CI 95%
confidence interval, SD standard deviation, CS change scores, ES effect size r (pre-post/pooled SD). Aβ = R-CPT at 2,000 Hz; C = R-CPT at 5 Hz; R-CPT ranged current perception threshold test. *Significance level

















scores or superficial palmar blood flow or skin temperature
(p > 0.05) after US therapy.
Discussion
Ultrasound therapy (3 MHz, pulsed US and 1 MHz,
continuous US) demonstrated a small to moderate effect
on skin blood flow (RBC concentration), skin temperature
and sensory perception thresholds at 5 Hz (C fibers) over
the treatment area in the distal forearms of healthy vol-
unteers. This study resulted in a significant reduction in
skin blood flow, skin temperature, and C fiber percep-
tion thresholds immediately after the 3 MHz pulsed US,
1 MHz continuous US, and control (rest). Whereas, the
sensory perception thresholds at 2,000 Hz (A-beta fibers)
remained unaltered by all three conditions (3 MHz, pulsed
US, 1 MHz, continuous US, and rest).
Previous studies have demonstrated that US has the
potential to decrease blood flow in rat models [44-46]
and human calf skin [47]. In the present study, the results
demonstrated that application of US (whether pulsed or
continuous) significantly decreases skin blood flow imme-
diately after therapy, thus supporting the work by Ware
et al. There was a decrease in skin blood flow over time
without the treatment (control/rest) as well, but the
changes observed were smaller (≤1.0 AU) when compared
to continuous US (3.5 AU) or pulsed US therapy (2.5 AU).
Our findings are consistent with Ware et al. who reported
an average decrease of 12% in dermal blood flow and ele-
vated skin temperatures averaging 1.4°C with continuous,
3 MHz US, using different measurement and treatment
procedures. They used laser Doppler flowmetry measured
from calf muscles, and a higher US dosage was imple-
mented including an intensity of 1.5 W/cm2 and a dur-
ation of 10 min [47]. Thus, the total energy delivered was
quite different than what was used in this current inves-
tigation. In contrast, our study found decreased skin
temperature along with decreased skin blood flow im-
mediately after the US application (both pulsed and
continuous US) (Figure 6). The current findings on
temperature in our study are similar to the previous re-
ports which have revealed that skin temperature decreases
with US intervention [48-50]. Bickford and Duff and Paul
and Lmig attributed their findings to the use of a water-
cooled applicator for the data collection [48,49], while
Kramer attributed the temperature changes to US trans-
mission gel [50]. It is known that when in contact with
cold materials, the skin tends to freeze at higher tempera-
tures than when exposed only to cold air due to a reduc-
tion in the amount of supercooling [51]. This may further
























Changes before and after US, control
pretest Abeta
posttest A beta
Figure 2 Sensory perception thresholds at 2,000 Hz before and



























Changes before and after  US, control
pretest C fibre
postest C fibre
Figure 3 Sensory perception thresholds at 5 Hz before and after US and control.
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skin (mild), which stimulates the cold-sensitive afferents
to activate sympathetic nerves to release norepinephrine,
leading to a local cutaneous vasoconstriction [26,52].
Thus, the underlying mechanism of the demonstrated
changes in superficial blood flow and skin temperature
in this study might have been due to the US transmis-
sion gel [50] and the metal plate of the US transducer
head [48,49].
Kramer demonstrated a linear relationship between sub-
cutaneous tissue temperature and US intensity [50]. In
their study, subcutaneous temperature increased linearly
with increasing intensity after 5 min of sonation, using a
frequency of 0.87 MHz. These authors [47] observed a sig-
nificant decrease in skin temperature during the first mi-
nute of sonation at 0.0 and 0.5 W/cm2 demonstrating a
rapid cooling effect and also during the recovery periods
at 1.5, 2.0, and 2.5 W/cm2 after the gel was wiped off from
the skin. It was not until US intensity had been increased
to 2.0 W/cm2 that the thermal heating effect of US ne-
gated the immediate superficial thermal-cooling effect of
the gel to produce significantly increased subcutaneous
tissue temperature during sonation. It was suggested that,
as US provided a deep heating effect, the US transmission
gel on the skin surface provided a superficial cooling effect
[50]. In the present study, we too observed a similar
temperature response to US therapy. Skin temperatures
decreased with 0.25 W/cm2, 3 MHz pulsed US as well as
with 0.8 W/cm2, 1 MHz continuous US, but the largest
drop in skin temperature was seen with 3 MHz pulsed US
at 0.25 W/cm2 (2°C p < 0.05) and not with the continuous
US at 0.8 W/cm2 (1.5°C, p < 0.05) or with control/rest
(≤ −0.3°C, p < 0.05). Therefore, it is suggested that there
will be minimal cooling in skin after the US application if
the cooling of the gel was counteracted by continuous US
or with use of higher intensities.
The current study demonstrated that there was no
change in A-beta perception threshold in the ring finger
after the application of pulsed US, continuous US, or
after control/rest (Figure 2). We could not find any study
that has looked at the sensory perception thresholds be-
fore and after US therapy in the distal forearms of healthy
volunteers. However, there are some previous reports on
median and radial nerve sensory nerve conduction veloci-
ties (sNCV) observed after US in healthy subjects using
variable intensities for different durations [52-55]. Because
conventional nerve conduction studies can measure the
conduction velocities of large diameter nerve fibers
[42,43], the responses most similar in our study would
be the 2,000-Hz R-CPT scores. Andrew et al. [52] found
no significant differences in the median nerve sNCV when
comparing the experimental groups (at three intensities:
0.5, 1.0, and 1.5 W/cm2) and control group (no US) with
the placebo group (0.0 W/cm2) after 10 min of US therapy
[52]. Therefore, it could be assumed that the application
of ultrasonic waves, either pulsed or continuous, has no
effect on the touch and pressure sensations in the area
supplied by median and ulnar nerves.
The present study also demonstrated that there was a
decrease in C fiber perception threshold in the ring finger
after the application of pulsed US, continuous US, or after
control/rest (Figure 3). We could not find any study which
looked at the sensory perception thresholds after US ther-
apy. But we can relate these findings to the previous re-
ports which have demonstrated that peripheral nerve
conduction responses after US vary according to the
subtype of nerve fibers. Several investigators have
shown that ‘B’ peripheral nerve fibers are most sensi-
tive to US, followed by ‘C’ fibers, while ‘A’ nerve
fibers were the least sensitive to US therapy [56-58]. De-
































Changes before and after US, control
pretest Bf
posttest Bf
Figure 4 Skin blood flow response before and after US and control.
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hypersensitivity or increased sensitivity; hence, we can
presume that changes observed in this study might have
been due to the increased responsiveness of C fibers to
US therapy. These changes in C fiber perception thresh-
old may be thought to help with pain modulation [59].
C fibers transmit polymodal nociceptive, slow pain,
temperature sensations, and carry postganglionic sympa-
thetic signals; hence, the decrease in sensory perception
thresholds associated with pulsed US and continuous
US might have been influenced by changes in skin
temperature through a thermal-cooling effect of the
US transmission gel or by the ultrasound itself. The
temperature of the forearm skin was comparatively
higher than the treatment area (2× ERA) where gel was
applied; hence, we can presume that this temperature dif-
ference caused a mild cooling effect on skin and lead to
the stimulation of sympathetic vasoconstriction and thus
reduced blood flow and temperature as mentioned earlier.
These immediate vasoconstrictor responses after mild
local cooling of skin requires both intact sensory and sym-
pathetic functions and are thought to manifest through
a complex combination of sensory, autonomic, and
Before 3 MHZ pulsed US After 3 MHz pulsed US
Before control-P After control-P
Before 1MHz Cont. US After 1MHz Cont. US
Before control-C After control-C
(a)
(b)
Figure 5 Skin blood flow responses. (a) Skin blood flow responses as seen on TiVi camera in the pulsed US group. (b) Skin blood flow
responses as seen on TiVi camera in the continuous US group.
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direct effects. This can further be explained by several
underlying mechanisms, involving effects on receptor
translocation, transmitter secretion and vascular
smooth muscle contractile function [26].
Differing construct parameters, methods of blood flow
measurement, skin temperature measurement, and treat-
ment protocols do not allow direct comparisons to be
made between the research studies that have been pub-
lished to date [30,47-50,52,60,61]. However, the observed
changes with US therapy are deductible from the previ-
ous physiological findings, but the underlying mechan-
ism of the demonstrated changes in skin blood flow,
skin temperature, and sensory perception thresholds ob-
tained with 5 Hz stimulation in the control are still un-
clear. The small changes observed in skin temperature
and skin blood flow after the control or rest period (3 to
5 min) might have been due to the emotional factors,
which were not under participants’ control. Whereas the
changes in sensory perception threshold at 5 Hz after
control/rest in both groups (3 MHz pulsed or 1 MHz
continuous US group) may have been due to the ‘wind-
up phenomenon’ [62], which is described as a frequency-
dependent increase in the excitability of spinal cord
neurons in response to the C fiber activity (repetitive
stimulation) [62]. The lowering of sensory perception
thresholds at 5 Hz in this study following repetitive
stimulation of C fibers is consistent with the previous
neurometer CPT findings of Wallace et al. and Farajida-
var et al. in the control group [62,63]. The changes ob-
served after control condition can also be explained by
order effect or learning effect from the repeated testing
on the neurometer. TiVi and infrared skin thermometer
are objective outcome measures, and they could not have
influenced the participants’ blood flow or temperature
responses while at rest. But the neurometer is both
subjective [40] (subjects have to respond to 5 Hz stimuli
and stop the test when they begin to feel the tingling or
buzzing sensation near the electrodes) and objective as-
sessment tool [40] and this might have had an influence
on the observed threshold responses. At the beginning,
participants were unaware of the transcutaneous electrical
stimulation from the neurometer and might have
responded with higher thresholds (higher baseline values),
but as the tests continued and repeated several times, they
become familiar with the test and type of stimulations
thus performing subsequent tests more fast and more
conveniently, indicating a possible learning effect [64].
It is also known from previous reviews that therapeutic
ultrasound is often used as a deep heating rehabilitation
modality for hand conditions [4,6]. The present investiga-
tion only examined the effect of ultrasound from superfi-
cial tissues in the distal forearms. TiVi can reflect red
blood cell concentrations from the skin at a depth of 0.4
to 0.5 mm (well into the reticular dermis), while the digital
infrared thermometer and R-CPT tests record temperature
and sensation superficially. Adequate washout was attained
before each pre-test for all measures. However, it is not
known, whether the dosage used for 3 MHz pulsed US
and 1 MHz continuous US in this study actually increased
or decreased the tissue blood flow and tissue temperatures
at a depth of 2 cm (for 3 MHz US) and 3–5 cm (for
1 MHz US ) or had no effect at all. Bickford and Duff re-
ported some conflicting responses like decreased subcuta-
neous and skin temperatures (superficial) along with
increased muscle blood flow (at a depth of 1 to 3 cm) after
sonating healthy tissues with 0.8 MHz, using higher inten-
sities (ranging from 2.0–3.0 W/cm2) [47,48]. These au-
thors [47] demonstrated that consistent sustained increase
in blood flow and tissue temperature in the deep muscles





























Changes before and after US, control
pretest Temp
posttest Temp
Figure 6 Skin temperature response before and after US and control.
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3.0 W/cm2), while the moderate intensities causes reduc-
tion in skin blood flow and skin temperature due to the ef-
fect of contact cooling with US applicator [47]. Lehmann
and Delateur reported that vigorous heating requires
higher total power outputs (up to 40 W) and higher US
intensities (up to 4 W/cm2) [65]. Most joints covered with
a significant amount of tissue (shoulder, hip) may be mod-
erately heated with a total power output of 10 to 20 W (at
1 to 2 W/cm2 US intensity) [65]. For very mild treatments,
or for small joints with minimal soft tissue cover, a total
output of 1 to 10 W (at 0.1–1.0 W/cm2 US intensity) may
be used for adequate heating [53]. Though tissue heating
is regarded as beneficial, Merrick et al. cautioned that it is
difficult to predict temperature increases when ultrasound
is applied clinically owing to a number of unknown vari-
ables, including the distance to reflecting soft tissue-
bone interfaces, variability among ultrasound machines,
the thickness of each tissue layer, and the amount of cir-
culation [12,18,66,67].
In summary, it is assumed that 3 MHz pulsed and
1 MHz continuous US at low intensities (0.25 and
0.8 W/Cm2 ) and short durations (5 and 3 min) in the
current study might have accounted at least in part for
the observed changes in skin blood flow, skin tempera-
tures, and C fiber perception thresholds, thus indicating
that US is not ineffective as a treatment modality but can
have some minor effects on the superficial tissues and C
fibers of sensory nerves.
Our study does not provide an indication about a thera-
peutic dosage. Another issue to be considered in our dos-
age was that we were sonating normal tissue, and the
physiological effects might be more dramatic if we were
dealing with injured tissue. We elected to study the
physiological effects in normal tissue because of a lack of
research in this area and it is important to start with a
simpler construct. Further, ethics boards are often unwill-
ing to allow research on human subjects with injuries or
disease until the testing has been applied to normal indi-
viduals. This would also suggest that future studies look-
ing at physiological effects of ultrasound on blood flow,
temperature, and sensory function should move towards
investigating larger dosages and patient populations
(damaged tissue).
Limitations and research recommendations
There are a number of limitations in the current study
that may have affected the study findings and generalizability.
Only one therapist provided the treatment and assessments,
which meant that the evaluator was not blinded. However,
three of these measures were not under control of the
therapist. The sensory threshold was determined by the
participant while the TiVi and thermometer were not con-
trolled by either the participant or therapist, so minimal
bias was expected with respect to outcome evaluation.
However, the TiVi system while accurate is only able to
measure superficial blood flow and the US effects in dee-
per tissue were not measured.
For the sensory evaluation, we used the rapid CPT as-
sessment which has less repetition than the full CPT
protocol, which involves a repeated force choice proto-
col. While this may have made our sensory measure-
ments less precise, it was deemed appropriate given we
were looking for transient changes and the forced choice
protocol can be more time-consuming and we may have
lost the opportunity to see the short-term changes. The
sensory perception thresholds were recorded from the
tip of ring fingers (dermatome supplied by C7 and C8),
instead of the treatment area in order to follow the rec-
ommended guidelines of the manufacturer, and to avoid
any unwanted motor point stimulation (muscle contrac-
tion) and thus may not reflect sensory changes in the
treatment area. Furthermore, since the ring is innervated
by both the median and ulnar nerves, differential effects
in these nerves were not directly explored.
Real-time measurements of skin blood flow and skin
temperature over the treatment area during the applica-
tion of US was not possible because of the continuous
movement of transducer head which was in-turn block-
ing the view of TiVi images. This is considered a min-
imal limitation since very transient effects are unlikely to
have therapeutic value.
As there is no standard for US dosage, the two US
doses (3 MHz pulsed and 1 MHz continuous) selected in
this study were based on the empirical evidence and
therapeutic principles of US therapy [20,33]. Hence, there
is a need to develop US therapy dosage guidelines for dif-
ferent disorders.
The responses observed in this study suggest that small
to moderate changes in skin blood flow, skin temperature,
and sensory nerve perceptions should be expected with
brief exposure to US therapy. Hence, there is a possibility
that the observed changes may have some beneficial effect
on the injured tissues. Knowledge about the short-term
and long-term physiologic effects of US also informs our
understanding of the safety and therapeutic benefit of US
therapy. Thus, future research should explore the effects
of US in patients with hand injuries and with comorbid
health problems using different dosages commonly used
in the clinical practice. Furthermore, responses from US
can be compared with the responses from other physical
agent modalities commonly used in hand rehabilitation to
help choose the best treatment for patients.
Conclusions
In conclusion, this study demonstrated that both 3 MHz
pulsed (1:4, 0.25 W/cm2, 5 min) and 1 MHz continuous
US (continuous, 0.8 W/cm2, 3 min) significantly de-
creased skin blood flow, skin temperatures, and C fiber
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perception thresholds immediately after US therapy.
There was no significant change in A-beta perception
thresholds, detecting touch, and pressure sensations with
US therapy, indicating the negligible effect of US on
these fibers. The changes observed in C fiber perception
thresholds after US indicate that these fibers are more
sensitive to US therapy and may have a potential role in
influencing the pain signals carried by C fibers which
needs further investigation. It is presumed that all these
physiologic responses observed could have been due to a
sympathetic vasoconstrictor effect as a result of thermal
changes (thermo-cooling effect of gel and transducer
head) or biochemical tissue responses to ultrasound or
due to a direct effect of US on C fibers belonging to me-
dian and ulnar nerves. However, further research using
different US dosages commonly used in clinical practice
settings would be required to definitively establish the
putative therapeutic effects and underlying physiologic
mechanism(s) of action of US and how they are influ-
enced by different parameter settings.
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